Related Experiment Video
Updated: Jul 2, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Nanomaterial-Based Strategies for Preventing Tumor Metastasis by Interrupting the Metastatic Biological Processes
Qingjin Cai1, Yijia He2, Yang Zhou1
1Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China.
Abstract:
Tumor metastasis is the primary cause of cancer-related deaths. The prevention of tumor metastasis has garnered notable interest and interrupting metastatic biological processes is considered a potential strategy for preventing tumor metastasis. The tumor microenvironment (TME), circulating tumor cells (CTCs), and premetastatic niche (PMN) play crucial roles in metastatic biological processes. These processes can be interrupted using nanomaterials due to their excellent physicochemical properties. However, most studies have focused on only one aspect of tumor metastasis. Here, the hypothesis that nanomaterials can be used to target metastatic biological processes and explore strategies to prevent tumor metastasis is highlighted. First, the metastatic biological processes and strategies involving nanomaterials acting on the TME, CTCs, and PMN to prevent tumor metastasis are briefly summarized. Further, the current challenges and prospects of nanomaterials in preventing tumor metastasis by interrupting metastatic biological processes are discussed. Nanomaterial-and multifunctional nanomaterial-based strategies for preventing tumor metastasis are advantageous for the long-term fight against tumor metastasis and their continued exploration will facilitate rapid progress in the prevention, diagnosis, and treatment of tumor metastasis. Novel perspectives are outlined for developing more effective strategies to prevent tumor metastasis, thereby improving the outcomes of patients with cancer.
Insights
Nanomaterials offer a promising strategy to combat cancer metastasis by targeting key biological processes. This approach aims to prevent tumor spread and improve patient outcomes.
Area of Science:
- Oncology
- Materials Science
- Nanotechnology
Background:
- Tumor metastasis is the leading cause of cancer mortality.
- Interrupting metastatic processes is a critical strategy for cancer treatment.
- The tumor microenvironment (TME), circulating tumor cells (CTCs), and premetastatic niche (PMN) are key players in metastasis.
Purpose of the Study:
- To highlight the potential of nanomaterials in targeting metastatic biological processes.
- To explore strategies for preventing tumor metastasis using nanomaterials.
- To discuss challenges and future prospects of nanomaterials in metastasis prevention.
Main Methods:
- Summarizing metastatic biological processes and nanomaterial-based intervention strategies.
- Analyzing nanomaterial applications targeting the TME, CTCs, and PMN.
- Reviewing current literature on nanomaterials for cancer metastasis prevention.
Main Results:
- Nanomaterials can be utilized to interrupt metastatic processes by acting on the TME, CTCs, and PMN.
- Multifunctional nanomaterials show significant advantages for long-term metastasis prevention.
- Targeting multiple aspects of metastasis with nanomaterials can enhance efficacy.
Conclusions:
- Nanomaterials provide a versatile platform for developing novel strategies against tumor metastasis.
- Continued exploration of nanomaterial-based approaches will accelerate progress in cancer prevention, diagnosis, and treatment.
- Developing effective nanomaterial strategies is crucial for improving cancer patient outcomes.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment

